Azilsartan protects against hyperglycemia-induced hyperpermeability of the blood-brain barrier

Azilsartan protects against hyperglycemia-induced hyperpermeability of the blood-brain barrier

Diabetes mellitus (DM) is a complex metabolic disease with significant neurological complications and is reported to be closely related to the blood-brain barrier (BBB) disruption. Azilsartan is an antagonist of the Angiotensin II receptor developed for the treatment of hypertension, and it has been...

Full description

Bibliographic Details
Main Authors: Jing Han, Hua Tang, Longfei Yao, Erliang Jin, Wanxi Pan, Shaojun Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Bioengineered
Subjects:
azilsartan
diabetes mellitus
blood-brain barrier
klf2
Online Access:http://dx.doi.org/10.1080/21655979.2021.1948950

Similar Items

Similar Items